The city of Tamarac, Florida, currently has 1 active clinical trials seeking participants for Type 2 Diabetes research studies.
A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)
Recruiting
The main purpose of this study is to evaluate additional dosing options for dulaglutide in pediatric participants with Type 2 Diabetes. Participation in this study will last about 8 months.
Gender:
ALL
Ages:
Between 10 years and 17 years
Trial Updated:
04/16/2025
Locations: D&H Tamarac Research Center, LLC, Tamarac, Florida
Conditions: Type 2 Diabetes